Long-term serologic follow-up of hepatitis C virus-seropositive homosexual men. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Long-term serologic follow-up of hepatitis C virus-seropositive homosexual men.

Clin Diagn Lab Immunol. 1995 Mar;2(2):219-24. Unique Identifier : AIDSLINE MED/95211639
Ndimbie OK; Nedjar S; Kingsley L; Riddle P; Rinaldo C; Department of Pathology, University of Pittsburgh Medical Center,; Pennsylvania.


Abstract: Hepatitis C virus (HCV) infection may go undiagnosed and continue to present a source of community-acquired or transfusion-associated infection because of shortcomings in sensitivity, specificity, and reproducibility of serologic tests. This project was designed to longitudinally study persons who were HCV seropositive or were at risk for seroconversion to characterize the course of infection. Sequential serum samples obtained semiannually from 617 homosexual male volunteers were available for study from the Pittsburgh site of the Multicenter AIDS Cohort Study. Testing by anti-HCV enzyme immunoassay (EIA) was performed on baseline (1984 to 1985) and most-recent (censor date, August 1992) samples. Selected samples were also assayed for alanine aminotransferase and by recombinant immunoblot (RIBA II) and nested PCR. A total of 17 of 617 (2.8%) men were HCV seropositive at entry. Of the 600 seronegative men, 9 converted to HCV seropositive during the study interval. Parenteral sources of exposure could be identified in 6 of these 26 HCV-seropositive men. Four men were HCV seropositive at baseline and seronegative at their most recent visit. Of the 26 HCV-seropositive men, 12 were also seropositive for human immunodeficiency virus. EIA analysis of 298 longitudinal samples from the 26 men revealed three patterns of HCV seropositivity: persistent, intermittent, and rare. Nine men (35%) showed intermittent or rare seropositivity with periods of over 1 year between some seropositive samples. PCR was positive in 76% of the HCV EIA-positive and 84% of the RIBA-positive samples. Thus, a low but significant number of homosexual men were HCV seropositive with variable positivity over several years of follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)
Keywords: Adult Aminotransferases/BLOOD Base Sequence Cohort Studies Follow-Up Studies Hepatitis C/*BLOOD/COMPLICATIONS/EPIDEMIOLOGY *Hepatitis C Viruses *Homosexuality, Male Human HIV Infections/COMPLICATIONS Immunoenzyme Techniques Longitudinal Studies Male Molecular Sequence Data Polymerase Chain Reaction RNA, Viral/ANALYSIS/GENETICS Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Time Factors JOURNAL ARTICLE MULTICENTER STUDYKWDadultaminotransferases/bloodbasesequencecohortstudiesfollow-upstudieshepatitisc/KWDblood/complications/epidemiologyKWDhepatitiscvirusesKWDhomosexuality,malehumanhivinfections/complicationsimmunoenzymetechniqueslongitudinalstudiesmalemolecularsequencedatapolymerasechainreactionrna,viral/analysis/geneticssupport,non-uKWDsKWDgov'tsupport,uKWDsKWDgov't,pKWDhKWDsKWDtimefactorsjournalarticlemulticenterstudy
950730
M9570896

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .